Extended Platelet Rich Fibrin in Mandibular Alveolar Ridge Splitting

Not Applicable

Not yet recruiting

• Conditions: Ridge Splitting

• Registration Number: NCT06637982
• Lead Sponsor: Mansoura University

Brief Summary

Thirty two healthy implants will be selected from the outpatient clinic of the oral and maxillofacial department of Mansoura university to be included in this study for replacement of lost posterior teeth with limited bone width.

Detailed Description

Not available

Study Timeline

• Status Verified: 2024-10
• Study First Submitted: 2024-10-07
• Study First Submitted QC: 2024-10-09
• Last Update Submitted: 2024-10-09
• Study Start: 2024-10-10
• Study First Posted: 2024-10-11
• Last Update Posted: 2024-10-11
• Primary Completion: 2025-04-10
• Study Completion: 2025-10-10

Recruitment & Eligibility

• Status: NOT_YET_RECRUITING
• Sex: All
• Target Recruitment: 32

Inclusion Criteria

• Patient age 18 years old and older.
• Patient's cooperation, motivation and good oral hygiene.
• Atrophic posterior mandible of horizontal alveolar dimension range between 3 - 6 mm at the crest, with minimum 10 mm vertical height from the alveolar crest to the superior border of the inferior alveolar canal.
• Absence of undercuts in buccal aspect of the ridge.
• Favorable occlusion and no parafunctional habits.
• Patients able to comply with the required recall visits.
• No gender preface in selection of the patients.
• Acceptable inter-arch space for the future prosthesis.

Exclusion Criteria

• Any pathological condition at the site of surgery.
• Patients with systemic diseases that contra-indicate the surgical procedure such as uncontrolled diabetes mellitus, bleeding disorders, serious osseous disorders, and mental disorders.
• Patient taking drugs that could affect bone healing process as immunosuppressive drugs and bisphosphonates.
• Heavy smoking and alcoholism.
• Parafunctional habits such as bruxism and clenching.
• Signs of acute infection or pus discharge.
• Untreated periodontal disease or bad oral hygiene.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
implant stability	9 months	the stability of the implants will be evaluated by RFA with the Osstell Mentor device
alveolar ridge width	9 months	alveolar ridge width will be measured preoperative, immediate postoperative and after 9 months

Trial Locations

Locations (1)

Mansoura University; 🇪🇬 Mansoura, Egypt, Egypt